newsfilter
← Latest News
GlobeNewswire·

Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine

FREMONT, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced a strategic